LEVIOSA: LEVOFLOXACIN-DEXAMETHASONE (OPHTHALMOLOGY, OCULAR INFECTION AND INFLAMMATION, CATARACT SURGERY)

LEVIOSA: LEVOFLOXACIN-DEXAMETHASONE (OPHTHALMOLOGY, OCULAR INFECTION AND INFLAMMATION, CATARACT SURGERY)
Product Description

Levofloxacin-Dexamethasone eye drops solution is the first combination approved for the management of patients undergoing cataract surgery able to prevent infection and ensure complete control of inflammation with one week treatment. Levofloxacin-Dexamethasone combines the power of the most active steroid (Dexamethasone 0,1%) and Levofloxacin 0,5%, a fluoroquinolone with a broad spectrum of action and activity on bacteria (Gram+ and Gram-) most frequently implicated in ocular infections. Levofloxacin-Dexamethasone indication is based on published Leader7 clinical study: an International, multicenter, randomized, blinded-assessor, parallel-group clinical study performed on more than 800 patients.

-           7 Scientific publication available

Presentation: eyedrops MD and SDU.IP protected.

NTC S.r.l.

  • IT
  • 2015
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)

NTC S.r.l.

  • IT
  • 2015
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)

More Products from NTC S.r.l. (29)

NTC S.r.l. resources (1)

  • Brochure Therapeutical areas - brochure

    Advanced scientific research and technology drive our efforts to innovate care practices.
    Our range of products builds from our historical vocation for innovation aimed at improving the experience of patients and healthcare practices.
    An innovation aimed at discovering specific therapeutic gestures: simple and intuitive,  sustainable, and technically advanced for empowering the patient.
    Our research aims to put pioneering new products within the reach of everyone and to optimize the
    performance of our products by analyzing the daily needs and habits of people undergoing treatment.
    We research, develop and produce innovative drugs, medical devices and food supplements.
    We market our products worldwide through licensing, distribution, marketing, and commercial deals with partner companies.
    Our core therapeutic areas are: Ophthalmology, Gastro-Metabolism, Pediatrics and Gynacology.